Skip to content

TO STUDY THE UTILITY OF HYPERTONIC SALINE NEBULIZER IN MANAGEMENT OF ACUTE BRONCHIOLITIS AND ITS SIDE EFFECTS.

UTILITY OF HYPERTONIC SALINE IN MANAGEMENT OF ACUTE BRONCHIOLITIS IN INFANTS

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/000080
Enrollment
100
Registered
2010-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hypertonic saline (3%) and Adrenalin: 4 ml hypertonic saline and 1 ml adrenalin given as nebulizer 1 hourly at admission and then 6 hrly till discharge. Control Intervention1: Normal sa

Sponsors

Dr Neeraj Dhawan
Lead Sponsor
Dr Praveena Dhiman
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Infants between the age group of two month to twelve months and admitted with clinical diagnosis of acute bronchiolitis.

Exclusion criteria

Exclusion criteria: 1.patient with recurrent episodes of wheezing, one or more episodes of respiratory distress in past 2.patients with family history of asthma,atopy. 3.presence of congenital heart disease. 4. history of prematurity and mechanical ventilation in newborn period. 5.very sick patients with shock, seizures, heart rate>180/min,respiratory rate of >100/min and adjudged to be in incipient resp. faliure. 6.grade 3 and 4 PEM 7.consolidation lung on x-ray chest. 8.foreingn body aspiration. 9.no child will be included in the study twice.

Design outcomes

Primary

MeasureTime frame
length of hospital stay.Timepoint:

Secondary

MeasureTime frame
1.improvement in RDAI score. 2. respiratory rate. 3.haemoglobin saturation. 4.heart rate. 5.number of add on treatment. 6.adverse events(tachycardia,pallor,tremor,nausea,vomiting)Timepoint:

Countries

India

Contacts

Public ContactDr Deepak Thakur
ndhawan_6144@yahoo.com0172 2731002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026